--- title: | Evotec (26) description: (26) --- [![Cyprotex | The Leading ADME-Tox Specialist](https://news.cyprotex.com/hs-fs/hubfs/cyprotex%20logo.png?width=224&height=62&name=cyprotex%20logo.png "Cyprotex | The Leading ADME-Tox Specialist")](https://www.cyprotex.com/) # Science Pool ## Evotec ### Recent Posts ## [Learn about our Global Anti-Infective Platform](https://news.cyprotex.com/sciencepool/learn-about-our-global-anti-infective-platform) Posted by [Evotec](https://news.cyprotex.com/sciencepool/author/evotec) on Mar 2, 2022 3:02:49 PM 0 Comments [Click here to read/write comments](https://news.cyprotex.com/sciencepool/learn-about-our-global-anti-infective-platform#comments-listing) Tags: [SP Standalone](https://news.cyprotex.com/sciencepool/tag/sp-standalone) ## [Read our Whitepaper: The Hollow Fibre Infection Model](https://news.cyprotex.com/sciencepool/hollow-fibre-whitepaper) Posted by [Evotec](https://news.cyprotex.com/sciencepool/author/evotec) on Mar 2, 2022 3:01:41 PM 0 Comments [Click here to read/write comments](https://news.cyprotex.com/sciencepool/hollow-fibre-whitepaper#comments-listing) Tags: [SP Standalone](https://news.cyprotex.com/sciencepool/tag/sp-standalone) ## [Read our Fact Sheet on the Hollow Fibre Infection Model](https://news.cyprotex.com/sciencepool/hollow-fibre-fact-sheet) Posted by [Evotec](https://news.cyprotex.com/sciencepool/author/evotec) on Mar 2, 2022 3:01:12 PM 0 Comments [Click here to read/write comments](https://news.cyprotex.com/sciencepool/hollow-fibre-fact-sheet#comments-listing) Tags: [SP Standalone](https://news.cyprotex.com/sciencepool/tag/sp-standalone) ## [Dive into our New Science Pool](https://news.cyprotex.com/sciencepool/bioinfect) Posted by [Evotec](https://news.cyprotex.com/sciencepool/author/evotec) on Mar 2, 2022 3:00:24 PM 0 Comments [Click here to read/write comments](https://news.cyprotex.com/sciencepool/bioinfect#comments-listing) Tags: [SP Standalone](https://news.cyprotex.com/sciencepool/tag/sp-standalone) ## [E.SOLVE: Solving Bioavailability Challenges Fact Sheet](https://news.cyprotex.com/sciencepool/e-solve-bioavailability-challenges-fact-sheet) Posted by [Evotec](https://news.cyprotex.com/sciencepool/author/evotec) on Mar 2, 2022 1:37:10 PM ![RZ_E_SOLVE-Logo+Tagline_211004_Screen_Blue-png](https://news.cyprotex.com/hs-fs/hubfs/RZ_E_SOLVE-Logo+Tagline_211004_Screen_Blue-png.png?width=259&name=RZ_E_SOLVE-Logo+Tagline_211004_Screen_Blue-png.png) E.SOLVE is Evotec's solution to accelerate your journey to the clinic supporting your formulation strategy as early as possible from discovery to market approval. Download this fact sheet to learn more about how E.SOLVE's full range of approaches improve solubilization and bioavailability to ensure that your API can progress through the drug discovery development pipeline faster. [DOWNLOAD](https://news.cyprotex.com/hubfs/Sciencepool/Fact%20sheets/Evotec%20Fact%20Sheets/Evotec-E.SOLVE_Factsheet.pdf) 0 Comments [Click here to read/write comments](https://news.cyprotex.com/sciencepool/e-solve-bioavailability-challenges-fact-sheet#comments-listing) Tags: [IND Enabling](https://news.cyprotex.com/sciencepool/tag/ind-enabling), [Fact Sheets](https://news.cyprotex.com/sciencepool/tag/fact-sheets), [Formulation & CMC](https://news.cyprotex.com/sciencepool/tag/formulation-cmc), [Toxicology & Safety](https://news.cyprotex.com/sciencepool/tag/toxicology-safety) ## [Regulated ADMET Services Fact Sheet](https://news.cyprotex.com/sciencepool/pcd-regulated-admet-fact-sheet) Posted by [Evotec](https://news.cyprotex.com/sciencepool/author/evotec) on Mar 2, 2022 1:34:27 PM Download this fact sheet to learn more about our regulatory ADMET services including: - Full support of development projects to fulfill and anticipate regulatory requirements - Accelerated development process with a full vision through all drug development phases up to filing - Dynamic team of expert scientists capable of handling projects of any complexity in regulated environment - Full integration with in-house bioanalytical and safety assessment groups - Tailored studies and programs based on specific client needs [DOWNLOAD](https://news.cyprotex.com/hubfs/Sciencepool/Fact%20sheets/Evotec%20Fact%20Sheets/factsheet-pcd-regulated-admet.pdf) 0 Comments [Click here to read/write comments](https://news.cyprotex.com/sciencepool/pcd-regulated-admet-fact-sheet#comments-listing) Tags: [Fact Sheets](https://news.cyprotex.com/sciencepool/tag/fact-sheets), [ADME/DMPK](https://news.cyprotex.com/sciencepool/tag/adme-dmpk), [IND Enabling Studies/Preclinical Development](https://news.cyprotex.com/sciencepool/tag/ind-enabling-studies-preclinical-development), [Toxicology & Safety](https://news.cyprotex.com/sciencepool/tag/toxicology-safety) ## [INDiGO-Select Fact Sheet](https://news.cyprotex.com/sciencepool/indigo-select-fact-sheet) Posted by [Evotec](https://news.cyprotex.com/sciencepool/author/evotec) on Mar 2, 2022 1:34:15 PM Learn more about how our INDiGO-*Select* services help in profiling and selecting your optimal clinical development candidate with: - Enhanced quality profile, speed of delivery, and probability of success of clinical candidates - Early identification of developability gaps and liabilities in selection process, enabling thorough de-risking of your candidate with flexible advanced lead optimization approaches - Managed by skilled discovery scientists and complemented by experienced drug development experts in CMC and preclinical development all under one roof [DOWNLOAD](https://news.cyprotex.com/hubfs/Sciencepool/Fact%20sheets/Evotec%20Fact%20Sheets/indigo-select-fact-sheet.pdf) 0 Comments [Click here to read/write comments](https://news.cyprotex.com/sciencepool/indigo-select-fact-sheet#comments-listing) Tags: [INDiGO](https://news.cyprotex.com/sciencepool/tag/indigo), [Fact Sheets](https://news.cyprotex.com/sciencepool/tag/fact-sheets), [IND Enabling Studies/Preclinical Development](https://news.cyprotex.com/sciencepool/tag/ind-enabling-studies-preclinical-development), [Toxicology & Safety](https://news.cyprotex.com/sciencepool/tag/toxicology-safety), [Clinical Development](https://news.cyprotex.com/sciencepool/tag/clinical-development) ## [Clinical Services Fact Sheet](https://news.cyprotex.com/sciencepool/clinical-services-fact-sheet) Posted by [Evotec](https://news.cyprotex.com/sciencepool/author/evotec) on Mar 2, 2022 1:12:17 PM Learn more about our clinical services platform including: - Fully integrated drug development services supporting preclinical and clinical needs, up to regulatory approval and commercial phases - Clinical supply suitable from First in Human to Phase III, fully GMP-compliant and with capacity to handle active ingredients classified up to OEB5 (OEL>0.5 µg/m³) - Additional capabilities such as API, formulation development, sample management, PK and statistical analyses, and metabolism [DOWNLOAD](https://news.cyprotex.com/hubfs/Sciencepool/Fact%20sheets/Evotec%20Fact%20Sheets/clinical-services-fact-sheet.pdf) 0 Comments [Click here to read/write comments](https://news.cyprotex.com/sciencepool/clinical-services-fact-sheet#comments-listing) Tags: [INDiGO](https://news.cyprotex.com/sciencepool/tag/indigo), [Fact Sheets](https://news.cyprotex.com/sciencepool/tag/fact-sheets), [IND Enabling Studies/Preclinical Development](https://news.cyprotex.com/sciencepool/tag/ind-enabling-studies-preclinical-development), [Clinical Development](https://news.cyprotex.com/sciencepool/tag/clinical-development) ## [NE-ADME (New Era of ADME & Beyond)](https://news.cyprotex.com/sciencepool/drug-discovery-2022-0-0) Posted by [Evotec](https://news.cyprotex.com/sciencepool/author/evotec) on Mar 2, 2022 10:05:18 AM Date: 16 June 2022 Location: Novartis Institutes for BioMedical Research, Cambridge, MA Attendees: Ralf Geiben Lynn, Sravani Adusumalli & Janice Lau Presenting: Sravani Adusumalli - Development of a High-Throughput and Efficient Automated Workflow to Determine Blood to Plasma Ratio [Learn more about NE-ADME (New Era of ADME & Beyond)](https://www.bostonsociety.org/NE-ADME/) 0 Comments [Click here to read/write comments](https://news.cyprotex.com/sciencepool/drug-discovery-2022-0-0#comments-listing) Tags: [Events](https://news.cyprotex.com/sciencepool/tag/events), [Cyprotex](https://news.cyprotex.com/sciencepool/tag/cyprotex) ## [Applied Pharmaceutical Toxicology 2022](https://news.cyprotex.com/sciencepool/drug-discovery-2022-0) Posted by [Evotec](https://news.cyprotex.com/sciencepool/author/evotec) on Mar 2, 2022 10:03:53 AM Date: 10-12 May 2022 Location: Vertex Pharmaceuticals, Boston, MA Attendees: Ralf Geiben Lynn & Chris Strock  Presenting: Identifying Seizures with MEA: Complementary Human and Rat Neuronal models enhance predictivity & High throughout RNA-seq profiling of 3D liver organoids to predict Drug Induced Liver Injury (DILI). - Chris Strock [Learn more about Applied Pharmaceutical Toxicology 2022](https://www.bostonsociety.org/APT/) 0 Comments [Click here to read/write comments](https://news.cyprotex.com/sciencepool/drug-discovery-2022-0#comments-listing) Tags: [Events](https://news.cyprotex.com/sciencepool/tag/events), [Cyprotex](https://news.cyprotex.com/sciencepool/tag/cyprotex) [Previous](https://news.cyprotex.com/sciencepool/author/evotec/page/25) [All posts](https://news.cyprotex.com/sciencepool/all) [Next](https://news.cyprotex.com/sciencepool/author/evotec/page/27)